Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis

Abstract In cancer patients, circulating cell-free DNA (cfDNA) includes tumor-derived DNA (tDNA). cfDNA has been used clinically for non-invasive gene mutation testing. The aim of this study was to characterize the features of the genetic alterations detected in cfDNA. This study included 6 patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hayato Koba, Hideharu Kimura, Taro Yoneda, Takashi Sone, Noriyuki Ohkura, Johsuke Hara, Kazuyoshi Hosomichi, Atsushi Tajima, Kazuo Kasahara
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ad43e947b89543268697b1f2e5f2c70a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ad43e947b89543268697b1f2e5f2c70a
record_format dspace
spelling oai:doaj.org-article:ad43e947b89543268697b1f2e5f2c70a2021-12-02T14:30:40ZMolecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis10.1038/s41598-021-87094-12045-2322https://doaj.org/article/ad43e947b89543268697b1f2e5f2c70a2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87094-1https://doaj.org/toc/2045-2322Abstract In cancer patients, circulating cell-free DNA (cfDNA) includes tumor-derived DNA (tDNA). cfDNA has been used clinically for non-invasive gene mutation testing. The aim of this study was to characterize the features of the genetic alterations detected in cfDNA. This study included 6 patients with primary lung cancer who died due to cancer progression. Tumors were biopsied at autopsy. Genetic alteration profiles were obtained using next generation sequencing. The features of the tDNA genetic alterations detected in cfDNA included a higher frequency of being present in multiple tumors (67% truncal mutations, 36% shared mutations, and 4% individual mutations) and a higher variant allele frequency (VAF; 47.6% versus 4.1% for tDNA alterations detected in cfDNA versus not detected in cfDNA, respectively). The data revealed that the tumor-derived genetic alterations most easily detected in cfDNA were truncal mutations with a high VAF. These results showed that essential genetic alterations enriched in cfDNA could help to characterize cancer cells and that genetic testing using cfDNA has advantages in the detection of fundamental regulatory aberrations occurring during tumorigenesis.Hayato KobaHideharu KimuraTaro YonedaTakashi SoneNoriyuki OhkuraJohsuke HaraKazuyoshi HosomichiAtsushi TajimaKazuo KasaharaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hayato Koba
Hideharu Kimura
Taro Yoneda
Takashi Sone
Noriyuki Ohkura
Johsuke Hara
Kazuyoshi Hosomichi
Atsushi Tajima
Kazuo Kasahara
Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
description Abstract In cancer patients, circulating cell-free DNA (cfDNA) includes tumor-derived DNA (tDNA). cfDNA has been used clinically for non-invasive gene mutation testing. The aim of this study was to characterize the features of the genetic alterations detected in cfDNA. This study included 6 patients with primary lung cancer who died due to cancer progression. Tumors were biopsied at autopsy. Genetic alteration profiles were obtained using next generation sequencing. The features of the tDNA genetic alterations detected in cfDNA included a higher frequency of being present in multiple tumors (67% truncal mutations, 36% shared mutations, and 4% individual mutations) and a higher variant allele frequency (VAF; 47.6% versus 4.1% for tDNA alterations detected in cfDNA versus not detected in cfDNA, respectively). The data revealed that the tumor-derived genetic alterations most easily detected in cfDNA were truncal mutations with a high VAF. These results showed that essential genetic alterations enriched in cfDNA could help to characterize cancer cells and that genetic testing using cfDNA has advantages in the detection of fundamental regulatory aberrations occurring during tumorigenesis.
format article
author Hayato Koba
Hideharu Kimura
Taro Yoneda
Takashi Sone
Noriyuki Ohkura
Johsuke Hara
Kazuyoshi Hosomichi
Atsushi Tajima
Kazuo Kasahara
author_facet Hayato Koba
Hideharu Kimura
Taro Yoneda
Takashi Sone
Noriyuki Ohkura
Johsuke Hara
Kazuyoshi Hosomichi
Atsushi Tajima
Kazuo Kasahara
author_sort Hayato Koba
title Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
title_short Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
title_full Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
title_fullStr Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
title_full_unstemmed Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
title_sort molecular features of tumor-derived genetic alterations in circulating cell-free dna in virtue of autopsy analysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ad43e947b89543268697b1f2e5f2c70a
work_keys_str_mv AT hayatokoba molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis
AT hideharukimura molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis
AT taroyoneda molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis
AT takashisone molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis
AT noriyukiohkura molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis
AT johsukehara molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis
AT kazuyoshihosomichi molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis
AT atsushitajima molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis
AT kazuokasahara molecularfeaturesoftumorderivedgeneticalterationsincirculatingcellfreednainvirtueofautopsyanalysis
_version_ 1718391213250314240